Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome c oxidase subunit 3 (MT-CO3) is a 261-amino acid, multi-pass transmembrane protein located in the inner mitochondrial membrane, forming one of the three core subunits of cytochrome c oxidase (complex IV), the terminal enzyme of the mitochondrial respiratory chain. MT-CO3 catalyzes the transfer of electrons from cytochrome c to molecular oxygen, coupled with proton pumping, thereby driving oxidative phosphorylation and ATP production. MT-CO3 is essential for cellular energy metabolism, with mutational defects causing mitochondrial diseases such as LHON, myopathy, and encephalomyopathy. Overexpression has been associated with breast cancer, indicating a possible role in cancer metabolism and a novel, albeit experimental, therapeutic target; preclinical studies have examined interactions with plant-derived compounds. Direct clinical interventions or approved drugs specifically against MT-CO3 are not yet established; targeting the enzyme carries inherent safety risks due to its essential role in normal cellular respiration.
Small molecules or natural compounds may bind to hydrophobic sites and modulate electron transport or oxidative phosphorylation (evidenced by in silico and docking studies, not clinically established); General mechanisms targeting mitochondrial respiration: inhibition of cytochrome c oxidase activity to disrupt ATP production or increase reactive oxygen species.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase subunit 3 (MT-CO3).